Insecticides India Ltd Q4 FY2024 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/xzr5p2v97jsmbghy5gggws8l.pdf

Key Takeaways


The Q4 Pause: Why Revenue Fell

Aggarwal: "The market did not have the confidence to store the material, so distributors bought only whatever they were having the regular sales, so they tried to skip the advance placements and we also did not place it strategically because we wanted to grow in the Q1 of the next year, so we did not push the market for that because the markets were falling."

Maharatna Strategy & Margin Delivery

Aggarwal: "The product should be the growing product and it should see growth at least from next 3 to 5 years. And to start with, the contribution from the product should be in the range of at least INR5 crores to INR10 crores."

Raw Material & Pricing Dynamics


Dahej Plant & OAT Agrio JV: The Medium-Term Build

Aggarwal: "I don't want to sound very aggressive because that will change earlier numbers, what you have in your books for us. So - but I can say it can have a potential of starting from INR50 crores, it can touch INR100 crores, INR150 crores, INR200 crores."

Growth Levers & Volume Ambition


Margin Path & Cost Structure

Aggarwal: "Interesting question, but you cannot make - talk about jumps actually immediately. So I would also love to jump if there is an opportunity. But yes, there will be a good growth. Difficult to say that 14%, 15% in two years is, it's not easy. So we'll go step-by-step growth."

Guidance & Commitments

CommitmentSpecificsTimeline
Dahej plant operationalFinal state clearances received, manufacturing begins2-3 months
New product launches6-7 products launchedJune-July FY25
OAT JV first product filingData generation complete, file submittedMid-2025 data; file immediately after
OAT JV first product market entryProduct launched in India first2026, or early 2027 if delayed
Volume growthInternal target of 20%+ volume growthFY25
B2C growthAt least 10% growthFY25
Export growthNo more than 2%-3% growthFY25
Nissan product launchesAt least 1 product per yearAnnual, ongoing
New AI introductionsAt least 3-4 new AIs per yearAnnual, ongoing
EBITDA marginReturn to double digitsNext 1-2 years

Key Metrics

MetricQ4 FY24
Revenue from operations₹273 cr, vs ₹302 cr in Q4 FY23
EBITDA₹0 cr, vs loss of ₹28 cr in Q4 FY23
PAT₹5 cr, vs loss of ~₹29 cr in Q4 FY23
FY24 revenue from operations₹1,966 cr, +9% YoY
FY24 EBITDA₹163 cr, +33% YoY
FY24 PAT₹102 cr, +62% YoY
FY24 volume growth~20%, value growth ~9%, prices fell ~10%
B2C revenue growth (FY24)~11%
B2B segment growth (FY24)5%
Maharatna share in B2C sales59%, up from 51% in FY23
Insecticide share of revenue (FY24)~45%, unchanged YoY
Herbicide share of revenue (FY24)33%, down from 40% in FY23
Fungicide share of revenue (FY24)19%, up from 12% in FY23
B2C segment share of sales (FY24)~69%
B2B segment share of sales (FY24)26%
Export share of sales (FY24)~5%
Market share in B2C domestic~5% to 5.5%
Working capital base150, optimized from 169
Debt equity ratio0.09%, improved from 0.18%
Advertisement and promotions expense₹25 cr to ₹30 cr annually
CWIP on balance sheet₹135 cr, major portion for Dahej L&T plant
New products launched in last 3-4 years contributed₹500+ cr
Q1 FY24 profitability dip from high-cost inventory~₹30 cr impact
Export growth expectation for next yearnot more than 2% or 3%
Dahej plant expected to be fully functioningin 2 to 3 months